Literature DB >> 18787905

Skin mapping with punch biopsies for defining margins in melanoma: when you don't know how far to go.

Lynn Dengel1, Kristin Turza, Mary-Margaret B Noland, James W Patterson, Craig L Slingluff.   

Abstract

BACKGROUND: Wide local excision of primary cutaneous melanoma usually provides clear margins and excellent local control. Nonclassical presentations of cutaneous melanoma, however, can challenge this treatment algorithm. Specifically, persistent melanoma-in-situ (MIS) at the margin not suspected clinically makes planning definitive wide local excision more difficult. We hypothesized that the use of punch biopsies as a mapping tool would allow us to obtain clear margins in these challenging cases.
METHODS: Punch biopsies were performed at sites 1 to 2 cm from prior positive margins. Subsequent wide local excision was planned, including all punch biopsy sites with positive findings: atypical melanocytic hyperplasia, MIS, or invasive melanoma. The management of three patients was documented prospectively. Standard surgical techniques were used independent of an experimental protocol. Medical records were reviewed, and data were summarized under institutional review board protocol HIC 10803.
RESULTS: The results of punch biopsies identified invasive melanoma, MIS, or atypical melanocytic hyperplasia in all three patients with MIS at the margins. All three mapping procedures were well tolerated and resulted in resection with negative margins in a single definitive resection.
CONCLUSION: Melanoma mapping with punch biopsy technique allows for definitive excision in cases when disease persists at the margins of the reexcision or in cases with unclear clinical examinations.

Entities:  

Mesh:

Year:  2008        PMID: 18787905      PMCID: PMC2852679          DOI: 10.1245/s10434-008-0138-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  24 in total

1.  Mohs' micrographic surgery using frozen sections alone may be unsuitable for detecting single atypical melanocytes at the margins of melanoma in situ.

Authors:  R J Barlow; C R White; N A Swanson
Journal:  Br J Dermatol       Date:  2002-02       Impact factor: 9.302

2.  Ultraviolet-assisted punch biopsy mapping for lentigo maligna melanoma.

Authors:  T T Jeneby; B Chang; L P Bucky
Journal:  Ann Plast Surg       Date:  2001-05       Impact factor: 1.539

3.  Interferon as adjuvant treatment for melanoma.

Authors:  Keith Wheatley; Natalie Ives; Barry Hancock; Martin Gore
Journal:  Lancet       Date:  2002-09-14       Impact factor: 79.321

Review 4.  Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials.

Authors:  Marko B Lens; Martin Dawes
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

5.  High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.

Authors:  J M Kirkwood; J G Ibrahim; J A Sosman; V K Sondak; S S Agarwala; M S Ernstoff; U Rao
Journal:  J Clin Oncol       Date:  2001-05-01       Impact factor: 44.544

6.  Treatment of lentigo maligna and lentigo maligna melanoma.

Authors:  G H Pitman; A W Kopf; R S Bart; P R Casson
Journal:  J Dermatol Surg Oncol       Date:  1979-09

7.  Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.

Authors:  John G Albertini; Dirk M Elston; Lester F Libow; Sidney B Smith; Mary F Farley
Journal:  Dermatol Surg       Date:  2002-08       Impact factor: 3.398

8.  Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.

Authors:  Shyamala C Huilgol; Dinesh Selva; Celia Chen; Dudley C Hill; Craig L James; Amanda Gramp; Raman Malhotra
Journal:  Arch Dermatol       Date:  2004-09

9.  A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma.

Authors:  John M Kirkwood; Judith Manola; Joseph Ibrahim; Vernon Sondak; Marc S Ernstoff; Uma Rao
Journal:  Clin Cancer Res       Date:  2004-03-01       Impact factor: 12.531

10.  Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence.

Authors:  Geoff Delaney; Michael Barton; Susannah Jacob
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

View more
  3 in total

1.  The Effectiveness of Mapping Biopsy in Patients with Extramammary Paget's Disease.

Authors:  Byung Jun Kim; Shin Ki Park; Hak Chang
Journal:  Arch Plast Surg       Date:  2014-11-03

2.  Correlation of Handheld Reflectance Confocal Microscopy With Radial Video Mosaicing for Margin Mapping of Lentigo Maligna and Lentigo Maligna Melanoma.

Authors:  Oriol Yélamos; Miguel Cordova; Nina Blank; Kivanc Kose; Stephen W Dusza; Erica Lee; Milind Rajadhyaksha; Kishwer S Nehal; Anthony M Rossi
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

3.  Automated video-mosaicking approach for confocal microscopic imaging in vivo: an approach to address challenges in imaging living tissue and extend field of view.

Authors:  Kivanc Kose; Mengran Gou; Oriol Yélamos; Miguel Cordova; Anthony M Rossi; Kishwer S Nehal; Eileen S Flores; Octavia Camps; Jennifer G Dy; Dana H Brooks; Milind Rajadhyaksha
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.